These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 34041167)
1. Comparative study on fasting and postprandial lipid profile in type 2 diabetes mellitus. Chahal J; Gupta S; Chawla SPS; Grewal H J Family Med Prim Care; 2021 Mar; 10(3):1288-1293. PubMed ID: 34041167 [TBL] [Abstract][Full Text] [Related]
2. A comparative study on the fasting and the postprandial dyslipidaemia in type 2 diabetes mellitus. Suryabhan L L; Chandrashekhar M I; Ratnendra R S; Prerna D N J Clin Diagn Res; 2013 Apr; 7(4):627-30. PubMed ID: 23730633 [TBL] [Abstract][Full Text] [Related]
3. Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. Kumar V; Madhu SV; Singh G; Gambhir JK J Assoc Physicians India; 2010 Oct; 58():603-7. PubMed ID: 21510110 [TBL] [Abstract][Full Text] [Related]
4. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Ozder A Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115 [TBL] [Abstract][Full Text] [Related]
5. Dyslipidemia Among Diabetes Mellitus Patients: A Case-Control Study From a Tertiary Care Hospital in South India. Latha VA; Mondu SSD; Dinesh Eshwar M; Polala AR; Nandanavanam S; Dodda S Cureus; 2023 Feb; 15(2):e35625. PubMed ID: 37007365 [TBL] [Abstract][Full Text] [Related]
6. Fasting and postprandial lipid parameters: A comparative evaluation of cardiovascular risk assessment in prediabetes and diabetes. Chakraborty M; Singh P; Dsouza JMP; Pethusamy K; Thatkar PV J Family Med Prim Care; 2020 Jan; 9(1):287-292. PubMed ID: 32110606 [TBL] [Abstract][Full Text] [Related]
7. Fasting Lipid Profile in Type 2 Diabetes- Necessity or Redundancy. Reddy DB; Kumar C; Mudgal S J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443344 [TBL] [Abstract][Full Text] [Related]
8. Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels. Cavallero E; Dachet C; Neufcour D; Wirquin E; Mathe D; Jacotot B Metabolism; 1994 Mar; 43(3):270-8. PubMed ID: 8139473 [TBL] [Abstract][Full Text] [Related]
10. Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia. Guan Y; Hou X; Tian P; Ren L; Tang Y; Song A; Zhao J; Gao L; Song G Front Endocrinol (Lausanne); 2021; 12():646185. PubMed ID: 33967959 [TBL] [Abstract][Full Text] [Related]
11. Comparative Evaluation of the Lipid Profile in the Serum of Patients with Type II Diabetes Mellitus and Healthy Individuals with Periodontitis. Thomas B; Prasad RB; Shetty S; Vishakh R Contemp Clin Dent; 2017; 8(1):96-101. PubMed ID: 28566858 [TBL] [Abstract][Full Text] [Related]
12. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia. Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574 [TBL] [Abstract][Full Text] [Related]
14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy. Habib SS; Aslam M; Naveed AK; Razi MS Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671 [TBL] [Abstract][Full Text] [Related]
15. Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study. Park CY; Park JY; Choi J; Kim DJ; Park KS; Yoon KH; Lee MK; Park SW Metabolism; 2016 Jun; 65(6):843-51. PubMed ID: 27173463 [TBL] [Abstract][Full Text] [Related]
16. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932 [TBL] [Abstract][Full Text] [Related]
17. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221 [TBL] [Abstract][Full Text] [Related]
18. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease. Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651 [TBL] [Abstract][Full Text] [Related]
19. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Weiss R; Harder M; Rowe J Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. Dixit AK; Dey R; Suresh A; Chaudhuri S; Panda AK; Mitra A; Hazra J J Diabetes Metab Disord; 2014; 13():58. PubMed ID: 24918095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]